PMID- 1372276 OWN - NLM STAT- MEDLINE DCOM- 19920417 LR - 20220318 IS - 0890-9369 (Print) IS - 0890-9369 (Linking) VI - 6 IP - 3 DP - 1992 Mar TI - Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. PG - 345-55 AB - Expression of the int-3 locus is activated in mouse mammary tumors as a consequence of insertional mutagenesis by the mouse mammary tumor virus (MMTV). Integration of the MMTV provirus into the int-3 locus promotes the transcription and translation of flanking cellular int-3 sequences sharing significant homology with the intracellular domain of the neurogenic Notch gene of Drosophila, and with the yeast cell cycle regulatory genes cdc10 and SWI6. To determine the in vivo consequences of activated int-3 expression, transgenic mice were generated harboring a genomic tumor DNA fragment consisting of the MMTV LTR and the flanking cellular int-3 sequences. All six int-3 founder transgenic mice and the progeny of one established line exhibited similar dramatic phenotypic abnormalities in tissues in which the transgene was expressed. Focal and often multiple poorly differentiated mammary and salivary adenocarcinomas appeared in the majority of transgenic mice between 2 and 7 months of age. Significantly, mammary glands were arrested in development and were lactation deficient in all female int-3 mice. The salivary glands, glands of the nasal mucosa and maxillary sinus, the extraorbital lacrimal glands, and the Harderian glands of juvenile and adult transgenic mice all contained proliferating immature ductule cells and were incompletely differentiated. In addition, all male int-3 transgenic mice were sterile, apparently the result of severe hyperplasia of the epididymis. These findings demonstrate in vivo that expression of the activated Notch-related int-3 gene causes deregulation of normal developmental controls and hyperproliferation of glandular epithelia. FAU - Jhappan, C AU - Jhappan C AD - Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892. FAU - Gallahan, D AU - Gallahan D FAU - Stahle, C AU - Stahle C FAU - Chu, E AU - Chu E FAU - Smith, G H AU - Smith GH FAU - Merlino, G AU - Merlino G FAU - Callahan, R AU - Callahan R LA - eng PT - Journal Article PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 63231-63-0 (RNA) RN - 9007-49-2 (DNA) SB - IM GS - cdc10 GS - int-3 GS - sw16 MH - Adenocarcinoma/genetics MH - Animals MH - Cell Differentiation/*genetics MH - Cell Transformation, Neoplastic/*genetics MH - DNA/genetics MH - Female MH - *Gene Expression MH - Hyperplasia/genetics MH - Male MH - Mammary Glands, Animal/*pathology MH - Mammary Neoplasms, Experimental/genetics MH - Mammary Tumor Virus, Mouse/*genetics MH - Mice MH - Mice, Transgenic MH - Plasmids MH - RNA/genetics MH - Salivary Gland Neoplasms/genetics MH - Salivary Glands/*pathology EDAT- 1992/03/01 00:00 MHDA- 1992/03/01 00:01 CRDT- 1992/03/01 00:00 PHST- 1992/03/01 00:00 [pubmed] PHST- 1992/03/01 00:01 [medline] PHST- 1992/03/01 00:00 [entrez] AID - 10.1101/gad.6.3.345 [doi] PST - ppublish SO - Genes Dev. 1992 Mar;6(3):345-55. doi: 10.1101/gad.6.3.345.